A phase II study of medroxyprogesterone acetate in patients with hormone receptor negative metastatic breast cancer: translational breast cancer research consortium trial 007
Crossref DOI link: https://doi.org/10.1007/s10549-014-3131-3
Published Online: 2014-09-26
Published Print: 2014-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Miller, Kathy D.
Althouse, Sandra K.
Nabell, Lisle
Rugo, Hope
Carey, Lisa
Kimmick, Gretchen
Jones, David R.
Merino, Maria J.
Steeg, Patricia S.
Text and Data Mining valid from 2014-09-26